Aganitha at Precision Medicine World Conference 2025
Visit us at booth #B722
Hear our success stories with AI in Showcase Track S1 on Day 1
The promise of AI as a transformative force for an end-to-end revolution in BioPharma R&D is yet to be fully realized. However, AI is already making a significant impact in specific areas of the R&D lifecycle, enabling:
🔬 The discovery of better targets and biomarkers
⚙️ Faster design, characterization, and optimization of therapeutics across various modalities, including SMOLs, antibodies, RNA therapies, ACGTs, peptides, and more.
👥 Smart cohorts, companion diagnostics, and effective endpoints.
We invite you to attend PMWC 2025, where our CEO, Vikram Duvvoori, will explore these exciting trends. In his talk, Vikram will present compelling case studies showcasing how generative AI and in silico modeling are unlocking insights from deep science to accelerate BioPharma R&D. Don’t miss this opportunity to gain valuable perspectives on the evolving role of AI in the industry.
Visit us at booth #B722
Ask us how Aganitha’s Agentic & Gen AI solutions can help you with
- Target & Biomarker research
- Indication expansion
- Patient stratification
- Small molecules, covalent binders & PROTACS
- Antibodies, Enzymes, Viral vectors for Gene therapies, ASO, mRNA & other RNA therapies delivered via LNPs
- CMC modeling
Ask us for demonstrations of our solutions listed below:
- Target & Biomarker Research with DBTIPS™: Triage and integrate signals from scientific literature, competitive landscape, multi-omics, and real-world evidence to accelerate target and biomarker identification, assessment, and validation across disease areas.
- NGS DataWorks™: Set up and run short and long-read sequencing-based multi-omics pipelines in your virtual private cloud using our infrastructure-as-code scripts.
- Bulk & Single-cell RNA-seq analysis with DISTILL™: Accelerate your journey from transcriptomic data to insights with AI-generated observations of differential gene expression, pathway enrichment, cell-cell communication, and multicellular programs.
- AI as Research Collaborator (ARC™): Supercharge LLMs with Aganitha AI agents that plug in proven computational tools & AI models, public & proprietary datasets to accelerate your R&D with AI as a competent & trustworthy scientific collaborator.
- AI catalysed enzyme engineering (ACE™): Accelerate enzyme engineering with Gen AI-powered property prediction & fitness optimization along with protein language model-powered evolution of enzyme designs.
- AI Agents in Research Team (ART™) of Chemistry: Accelerate and elevate small molecule engineering and CMC modeling with Aganitha AI agents joining your research team.
You can schedule a discussion using the button below.